Daniel Spiegelman
2018
Compensation breakdown
| Non-Equity Incentive Plan | $482,400 |
|---|---|
| Option Awards | $1,335,054 |
| Salary | $593,269 |
| Stock Awards | $2,085,908 |
| Other | $25,072 |
| Total | $4,521,703 |
Spiegelman received $2.1M in stock awards, accounting for 46% of the total pay in 2018.
Spiegelman also received $482.4K in non-equity incentive plan, $1.3M in option awards, $593.3K in salary and $25.1K in other compensation.
Rankings
In 2018, Daniel Spiegelman's compensation ranked 2,329th out of 14,244 executives tracked by ExecPay. In other words, Spiegelman earned more than 83.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,329 out of 14,244 | 84th |
Division Manufacturing | 853 out of 5,765 | 85th |
Major group Chemicals And Allied Products | 288 out of 2,128 | 87th |
Industry group Drugs | 232 out of 1,817 | 87th |
Industry Pharmaceutical Preparations | 180 out of 1,391 | 87th |
Pay ratio
| Daniel Spiegelman's Pay | $4,521,703 |
|---|---|
| Median Employee's Pay | $160,698 |
| Pay Ratio | 28to 1 |
In 2018, the annual total compensation of Daniel Spiegelman was $4,521,703.
The annual total compensation of the median employee at BioMarin Pharmaceutical was $160,698.
The ratio of Daniel Spiegelman's pay to the pay of median employee was therefore 28 to one.
Spiegelman's colleagues
We found five more compensation records of executives who worked with Daniel Spiegelman at BioMarin Pharmaceutical in 2018.
2018
Jean-Jacques Bienaim
BioMarin Pharmaceutical
Chief Executive Officer
2018
Henry Fuchs
BioMarin Pharmaceutical
President, Worldwide R&D
2018
Jeff Ajer
BioMarin Pharmaceutical
Executive Vice President, Chief Commercial Officer
2018
Robert Baffi
BioMarin Pharmaceutical
Executive Vice President, Technical Operations
2018
Brian Mueller
BioMarin Pharmaceutical